for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated ...
Sickle cell disease impacts more than 100,000 people in the United States. It’s estimated that more than two million ...
There will be a blood drive for sickle cell disease – the most common inherited blood disorder – this weekend in South Jersey ...
HealthDay on MSN5d
Premature Aging in Brains of Sickle Cell PatientsPeople with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in ...
WCBD Charleston on MSN2d
Circle of Hope: Raising awareness about sickle cell diseaseSomeone in the United States requires a blood transfusion every two seconds. For individuals fighting sickle cell disease, ...
We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.
Discover the latest addition to Children's Hospital Los Angeles' 10 cell and gene therapy treatments, including Casgevy for sickle cell disease ...
The Daily Monitor on MSN6d
Budaka registers drop in Sickle cell disease casesStatistics from the district health department indicate that in 2023, suspected cases of sickle cells stood at 1,456 and in 2024, the registered cases were 914. Thank you for reading Nation.Africa ...
In this Healio Video Perspective from Retina 2025, Adrienne W. Scott, MD, of Johns Hopkins University School of Medicine, ...
Adults with sickle cell anemia (SCA) and healthy controls with greater economic deprivation have older brain age.
Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback